Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Accept all cookies Reject all non-essential cookies

portrait

portrait

Websites

  • Sky news

    Findings from the C-MORE - multiorgan MRI Study

  • BBC news

    Findings from the C-MORE - multiorgan MRI Study

  • BBC world radio

    Betty Raman presenting findings from the C-MORE study (8:20)

Betty Raman

MBBS DPhil FESC FRACP

Professor Betty Raman

  • Assoc Professor of Cardiovascular Medicine
  • NIHR South Central RRDN Cardiology Specialty Lead
  • Hon. Consultant Cardiologist (Loc)
  • Wellcome Career Development Award Fellow
  • RDM Cardiovascular Medicine EDI Champion

I am a senior clinical academic cardiologist specialising in advanced cardiovascular imaging (CMR and Cardiac CT) and inherited and cardiomyopathic heart disease, leading a translational research programme that bridges mechanistic discovery, clinical application, and innovation in drug development.

 After completing specialist training in cardiology in Australia (FRACP), I joined the University of Oxford in 2015 to pursue a DPhil in Hypertrophic Cardiomyopathy (HCM)-the leading cause of sudden cardiac death in young adults and athletes. My doctoral work led to the development of a novel oxygen-sensitive magnetic resonance method that detects myocardial hypoxia non-invasively and holds promise as an early biomarker of disease activity. This pioneering work has been recognised internationally (ESC, AHA, BSCMR, SCMR, and BCS awards).

 Building on this foundation, I was awarded a British Heart Foundation Transition Fellowship (2020) and subsequently a Wellcome Career Development Award (2024) to advance a multi-disciplinary programme integrating imaging, genetics, energetics, and computational modelling. My goal is to identify and validate early markers of disease progression in HCM and related cardiomyopathies, enabling more precise risk prediction and accelerating evaluation of emerging therapies.

During the COVID-19 pandemic, I led the C-MORE study, a large multi-centre initiative that combined MRI, cardiopulmonary exercise testing, and cognitive assessments to characterise the long-term, multi-organ consequences of COVID-19. This work helped shape understanding of post-viral cardiovascular and systemic recovery.

My current research focuses on:

1)    Early-stage disease detection and monitoring in cardiomyopathies using next-generation CMR (BOLD, DTI, spectroscopy, radiomics).

2)    Mechanistic biomarkers to support early-phase and adaptive clinical trials. 

3)    Cross-organ interactions in cardiometabolic disease, integrating heart-brain-liver-renal imaging.

As a senior academic leader, I collaborate widely across academia, the NHS, and industry to translate advanced imaging into clinical and commercial impact. I actively welcome scientific collaborators, students, and industrial partners interested in biomarker discovery, imaging-enabled trial design, and AI-based modelling for cardiovascular disease.

Recent publications

More publications